Deregulated microRNAs and Adiponectin in Postmenopausal Women with Breast Cancer

被引:14
|
作者
Isabel Pena-Cano, Maria [1 ]
Saucedo, Renata [2 ]
Morales-Avila, Enrique [1 ]
Valencia, Jorge [2 ]
Zavala-Moha, Jose A. [3 ]
Lopez, Adriana [4 ]
机构
[1] Univ Autonoma Estado Mexico, Fac Chem, Toluca, Mexico
[2] Inst Mexicano Seguro Social, Endocrine Res Unit, Natl Med Ctr, Cuauhtemoc 330, Mexico City 06720, DF, Mexico
[3] Reg Hosp 251, Inst Mexicano Seguro Social, Oncol Dept, Mexico City, DF, Mexico
[4] Reg Hosp 251, Inst Mexicano Seguro Social, Pathol Dept, Mexico City, DF, Mexico
关键词
Breast cancer; Menopause; Obesity; MicroRNA; Adiponectin; Leptin; Insulin-like growth factors; MIR-17-92; CLUSTER; OBESITY; OVERWEIGHT; EXPRESSION; LEPTIN; SERUM; METABOLISM; MECHANISMS; MORTALITY; DIAGNOSIS;
D O I
10.1159/000496340
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Obesity is a risk factor for breast cancer (BC). Some mechanisms through which obesity can lead to cancer development are insulin-like growth factors (IGFs), adipokines, and microRNAs (miRs). The objective of the study was to determine whether miR-17-5p, miR-195-5p, and miR-2213p expressions were deregulated in serum samples of obese and nonobese postmenopausal women with BC. In addition, insulin, adiponectin, leptin and IGFs were analyzed. Methods: Fifty postmenopausal women with newly diagnosed BC and 50 postmenopausal healthy women were evaluated. Differences in miRs between BC and healthy cases and between obese and lean participants were analyzed. Receiver operating characteristic curves for miRs for discriminating patients with or without BC were established, and relationships between the miRs, adipokines, and breast tumor characteristics were also investigated. Results: miR-17-5p and miR-195-5p were higher in patients with BC in comparison to the controls, while miR-221-3p and adiponectin were significantly lower. Increased levels of miR-195-5p allowed the differentiation of BC from controls with a sensitivity of 83.3 and a specificity of 78.3%, and were associated with lobular and poorly differentiated cancer. There was no difference in miRs levels between obese and lean groups. Conclusions: Circulating miRs and adiponectin were deregulated in postmenopausal women with BC. (C) 2019 S. Karger AG, Basel
引用
收藏
页码:369 / 377
页数:9
相关论文
共 50 条
  • [21] Breast cancer and hormone therapy in postmenopausal women
    Turner, LE
    Bundred, NJ
    BRITISH JOURNAL OF CANCER, 2004, 91 : S27 - S27
  • [22] Breast cancer mimicking fibroadenomas in postmenopausal women
    Khout, Hazem
    Mohiuddin, M. Khalid
    Veeratterapillay, Rajan
    Fasih, Tarannum
    INTERNATIONAL JOURNAL OF SURGERY, 2011, 9 (01) : 2 - 4
  • [23] HORMONOTHERAPY AND LIPIDS IN POSTMENOPAUSAL WOMEN WITH BREAST CANCER
    Kypridemos, C.
    Rossios, K.
    Traianou, K.
    Dontas, C.
    Lagra, F.
    Krokidis, X.
    Papantoniou, S.
    Papadopoulou-Zekeridou, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 125 - 125
  • [24] Diabetes link to breast cancer in postmenopausal women
    不详
    AFRICAN JOURNAL OF DIABETES MEDICINE, 2012, 20 (02): : 26 - 26
  • [25] Hormonal therapy in postmenopausal women with breast cancer
    Campos, SM
    Winer, EP
    ONCOLOGY, 2003, 64 (04) : 289 - 299
  • [26] Downregulation of tumor suppressive microRNAs in vivo in dense breast tissue of postmenopausal women
    Abrahamsson, Annelie
    Capodanno, Alessandra
    Rzepecka, Anna
    Dabrosin, Charlotta
    ONCOTARGET, 2017, 8 (54) : 92134 - 92142
  • [27] ESTROGEN PRODUCTION AND METABOLISM IN NORMAL POSTMENOPAUSAL WOMEN AND POSTMENOPAUSAL WOMEN WITH BREAST OR ENDOMETRIAL CANCER
    REED, MJ
    BERANEK, PA
    GHILCHIK, MW
    JAMES, VHT
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (11): : 1395 - 1400
  • [28] DEREGULATED CELL CYCLE CONFERS RESISTANCE TO AROMATASE INHIBITORS IN POSTMENOPAUSAL BREAST CANCER PATIENTS
    Doostan, I.
    Karakas, C.
    Keyomarsi, K.
    Doostan, I.
    Keyomarsi, K.
    Moulder, S.
    Hunt, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (04) : 680 - 680
  • [29] Adiponectin, leptin and breast cancer in high risk postmenopausal women: Results from a nested case-control study
    Macis, Debora
    Sestak, Ivana
    Aristarco, Valentina
    Johansson, Harriet
    Guerrieri-Gonzaga, Aliana
    Decensi, Andrea
    Bonanni, Bernardo
    Cuzick, Jack
    Gandini, Sara
    CANCER RESEARCH, 2018, 78 (13)
  • [30] Similar to Adiponectin, Serum Levels of Osteocalcin are Associated with Mammographic Breast Density in Postmenopausal Women
    Vega, Sara
    Basurto, Lourdes
    Saucedo, Renata
    Barrera, Susana
    Reyes-Maldonado, Elba
    Garcia-Latorre, Ethel A.
    Zarate, Arturo
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2018, 40 (02) : 186 - 192